Til transaksjoner
Helse & omsorg

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

PanTera, an IBA and SCK CEN joint venture, aims to secure the large-scale production of actinium-225 (225Ac), which is one of the most promising alpha-emitting radioisotopes to fight cancer. The funds raised will be used primarily toward the construction of a state-of-the-art production facility in Belgium. This facility will not only enable large-scale production, it will also help fulfill PanTera’s ultimate goal to improve the accessibility of future, innovative cancer therapy based on 225Ac and theranostics.

Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

TRANSAKSJONSTYPE
Andre tjenester
Parter

Kontakt ansvarlige rådgivere

Cédric Michils

Cédric Michils

Managing Director
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss
Bart Delusinne

Bart Delusinne

Managing Director
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss
Nicolas Lambers

Nicolas Lambers

Associate Director
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss
Michaël Rixhon

Michaël Rixhon

Associate Director
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss
Nicholas Matthyssens

Nicholas Matthyssens

Senior Associate
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss
Robin Bundervoet

Robin Bundervoet

Associate
Brussel, Belgia
Oaklins KBC Securities
Se profil Ta kontakt med oss

Relaterte transaksjoner

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Finansielle tjenester | Helse & omsorg

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Les mer
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Helse & omsorg

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Les mer
Afric Phar has been acquired by Pharma Capital
Helse & omsorg

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Les mer